Drugs / H5N1 pISV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03816878 | Jan → Apr 2019 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H5N1 pISV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03816878 ↗ |
| Modality | Vaccine | “inactivated subunit H5N1 influenza vaccine” NCT03816878 ↗ |
| Route | Intramuscular | “Administered as an intramuscular (IM) injection” NCT03816878 ↗ |